The large number of human solid tumors such as colon, lung, pancreas, stomach, liver, head and neck carcinomas, in which the overexpression of NKG2A receptor and/or their ligand HLA-E has been often associated with a poor prognosis (3–5). This evidence concerns the gene HLA-E and head and neck carcinoma.